Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.

Je-Ming Hu,Yu-Ching Chou,Chang-Chieh Wu,Cheng-Wen Hsiao,Chia-Cheng Lee,Chun-Ting Chen, Sheng-I Hu,Wei-Tin Liu,Shu-Wen Jao

Journal of the Chinese Medical Association（2016）

引用 7|浏览21

暂无评分

摘要

Adjuvant CMT treatment of low-risk Stage II colon cancer patients with UFUR for more than 12 months following surgery improves DFS over surgery alone.

查看译文

关键词

adjuvant chemotherapy,disease-free survival,low-risk Stage II colon cancer,overall survival,tegafur/uracil

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要